AI assistant
BeOne Medicines Ltd. — Director's Dealing 2025
Jun 12, 2025
30073_dirs_2025-06-12_16b50717-93da-44e5-9a6c-05cf7d8432dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BeOne Medicines Ltd. (ONC)
CIK: 0001651308
Period of Report: 2025-06-10
Reporting Person: Ball Titus B. (Principal Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-10 | Ordinary Shares | A | 29601 | — | Acquired | 73983 | Direct |
| 2025-06-11 | American Depositary Shares | S | 134 | $258.3586 | Disposed | 0 | Direct |
Footnotes
F1: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
F2: Each American Depositary Share represents 13 Ordinary Shares.
F3: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service.